Glowing dye lights up cancer cells during surgery
NCT ID NCT05900986
Summary
This study is testing a new fluorescent dye called LS301-IT. It is given by IV before surgery to help surgeons see the edges of breast cancer tissue and nearby lymph nodes more clearly. The main goals are to check if the dye is safe and to see how well it helps guide surgery for women with early-stage breast cancer or DCIS.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Integro Theranostics Clinical Research Site #8
Winston-Salem, North Carolina, 27103, United States
-
Integro Theranostics Research Site #10
Cleveland, Ohio, 44195, United States
-
Integro Theranostics Research Site #12
Washington D.C., District of Columbia, 20059, United States
-
Integro Theranostics Research Site #2
Scottsdale, Arizona, 85260, United States
-
Integro Theranostics Research Site #3
Dallas, Texas, 75290, United States
-
Integro Theranostics Research Site #5
Philadelphia, Pennsylvania, 19107, United States
-
Integro Theranostics Research Site #6
The Bronx, New York, 10461, United States
-
Integro Theranostics Research Site #9
Weston, Florida, 33331, United States
-
Integro Theronostics Research Site #1
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.